Rotterdam

• Rituximab-induced remission in CIDP (ReCIX study) Recruiting
  2024-512506-25-00 5 2024-10-07 Chronic inflammatory demyelinating polyneuropathy (CIDP)
• Bio-equivalence of Rosuvastatin 10 mg Recruiting
  2023-509661-21-00 2 2024-10-03 Healthy volunteers
• Clinical trial comparing MK-2870 given with pembrolizumab to pembrolizumab alone in participants who have had surgery for NSCLC Recruiting
  2023-508012-35-00 5 2024-10-02 Newly diagnosed NSCLC with resectable clinical Stage II, IIIA or IIIB
• Tranexamic acid to prevent OpeRation in Chronic subdural Hematoma (TORCH) Recruiting
  2024-514927-40-02 11 2024-10-01 Chronic Subdural Hematoma
• A lower dose olaparib, combined with a drug which inhibits olaparib degradation, to increase tolerability and decrease the price of the trea … Recruiting
  2024-516414-38-00 11 2024-10-01 Cancer
• Comparing the effectiveness of tofacitinib extended release (XR) chronotherapy, morning versus evening dosing, in rheumatoid arthritis (RA) … Recruiting
  2024-517865-17-01 6 2024-09-30 Rheumatoid arthritis or psoriatic arthritis according to respectively
• Efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled clinical trial. (EDIT-CAS) Recruiting
  2023-507782-25-00 10 2024-09-27 Coronary vasomotor dysfunction (spasm)
• A Placebo-Controlled Study of Inhaled Pirfenidone in Progressive Pulmonary Fibrosis Recruiting
  2023-508429-29-00 4 2024-09-26 Progressive Pulmonary Fibrosis
• PREOPANC-5 Recruiting
  2023-508707-20-00 9 2024-09-19 Borderline resectable pancreatic cancer (BRPC)
• Personalized dosing of FOLFIRINOX in pancreatic cancer patients: a phase-2 pharmacokinetic, safety and feasibility trial Recruiting
  2024-510576-21-00 4 2024-09-18 Pancreatic cancer
• A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10 … Recruiting
  2023-507353-15-00 5 2024-09-10 idiopathic pulmonary fibrosis (IPF)
• Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NV … Recruiting
  2024-516195-15-00 5 2024-09-10 Advanced NSCLC
• A Phase I/II Study of AZD5863 in Adult Participants with Advanced or Metastatic Solid Tumors Recruiting
  2023-504139-42-00 7 2024-09-06 Advanced or metastatic solid tumors
• A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Recruiting
  2023-506642-23-01 4 2024-08-28 Active Pulmonary Sarcoidosis
• Intravenous iron to treat postoperative anaemia in older cardiac surgery patients: a randomized controlled trial (AGE ANAEMIA study) Recruiting
  2024-515920-35-01 6 2024-08-22 iron deficiency anaemia
• First-in-human study of 225Ac-PSMA-Trillium (BAY 3563254) in participants with advanced metastatic castration-resistant prostate cancer (mCR … Recruiting
  2023-507486-26-00 1 2024-08-20 Advanced metastatic castration-resistant prostate cancer with prostate
• HOVON 170 DLBCL: ANTICIPATE: Prevention of ANThracycline-Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B-cell ly … Recruiting
  2023-505377-32-00 5 2024-08-15 Diffuse large B-cell lymphoma (DLBCL)
• Dendritic cell therapy combined with surgery in mesothelioma (ENSURE) Recruiting
  2024-514054-70-00 1 2024-08-12 Adult patients diagnosed with resectable epithelioid MPM, following fi
• COMPARE STEMI ONE- Comparison Of reduced DAPT followed by P2Y12 inhibitor Monotherapy with Prasugrel vs stAndard Regimen in STEMI patients t … Recruiting
  2024-515883-30-00 6 2024-08-01 St-Elevated Myocardial Infartion
• A study to test the effects and safety of riliprubart in people with chronic inflammatory demyelinating polyneuropathy (CIDP) for which the … Recruiting
  2023-506503-26-00 5 2024-07-31 Polyneuropathy, Inflammatory Demyelinating, Chronic
• A Study to Evaluate Whether Healing all Bowel Wall Layers is a Superior Treatment Target in Patients with Active Crohn’s Disease (CD). Recruiting
  2023-509096-16-00 6 2024-07-31 Moderately to Severely Active Crohn’s Disease
• SALVOVAR trial: A pragmatic randomized phase III trial to assess the utility of adjusting chemotherapy dose & dosing schedule with the SALVa … Recruiting
  2023-508260-30-01 5 2024-07-30 Patients with poor prognostic OVARian cancers based on the tumor prima
• A long-term follow-up study for patients treated with Galapagos CAR T cell therapies Recruiting
  2023-510173-34-00 5 2024-07-26 Relapsed/refractory multiple myeloma
• CLEAR-PATH trial Recruiting
  2024-513363-15-01 11 2024-07-22 (Chronic) Peripheral (occlusive) arterial disease (PAD)

Showing 313–336 of 818 trials